About Jennifer Schmitke
Jennifer Schmitke is a chief operations officer and head of R&D at Consano Bio.
Experience
This experience comes from Jennifer Schmitke's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jennifer Schmitke in the role, so the role may have started earlier or lasted longer.
Consano Bio, Inc. Current
Chief Operations Officer and Head of R&D
Chief Operating Officer, Head of R&D (2023 – Present)
2023 – Present · Burlington, MA
Develops an investigational non-opioid treatment for people with chronic sciatica.
II
IMV Inc.
Executive Consultant, Interim Chief Operating Officer
2022 – 2023
EP
Epizyme
Senior Vice President, Technical Operations and Quality, Portfolio and Program Management
2021 – 2022
MT
Magenta Therapeutics
VP, Head of Program Management
2019 – 2021
OT
Omega Therapeutics
VP, Head of Program Management and Product Development
2017 – 2019
BI
Biogen
Senior Director, Program Leadership
2014 – 2016
AL
Alkermes
Program Director
2010 – 2014
Key Colleagues at Startups
The people Jennifer Schmitke works with at each company, as listed on that company's latest Form D.
Consano Bio, Inc. · Form D, Mar 20, 2026
MP
Michael Pede
Director
BA
Bill Abbington
Director
JC
John Conway
Director
JS
Joe Schiesl
Director
CC
Christopher Centeno
Director
DW
Doug Weide
Director
Andrew Hall
Chief Executive Officer and Board Member
JA
Jerome Adams
Director